N Engl J Med 382 (6): 514-524, 2020.[PUBMED Abstract] Tripathy D, Im SA, Colleoni M, et al.: Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
Lancet Oncol 19 (7): 904-915, 2018.[PUBMED Abstract] Im SA, Lu YS, Bardia A, et al.: Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer.
N Engl J Med 381 (4): 307-316, 2019.[PUBMED Abstract] Goetz MP, Toi M, Campone M, et al.: MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer.
J Clin Oncol 35 (32): 3638-3646, 2017.[PUBMED Abstract] Goetz MP, Toi M, Huober J, et al.: Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3.